Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody

Cell Signaling Technology Inc., Danvers, MA, USA.
The American journal of surgical pathology (Impact Factor: 5.15). 05/2009; 33(7):984-91. DOI: 10.1097/PAS.0b013e318198d666
Source: PubMed

ABSTRACT NUT midline carcinoma (NMC) is a uniformly lethal malignancy that is defined by rearrangement of the nuclear protein in testis (NUT) gene on chromosome 15q14. NMCs are morphologically indistinguishable from other poorly differentiated carcinomas, and the diagnosis is usually made currently by fluorescence in situ hybridization (FISH). As normal NUT expression is confined to testis and ovary, we reasoned that an immunohistochemical (IHC) stain for NUT would be useful in diagnosing NMC. To this end, we raised a highly specific rabbit monoclonal antibody, C52, against a recombinant NUT polypeptide, and developed an IHC staining protocol. The sensitivity and specificity of C52 staining was evaluated in a panel of 1068 tissues, predominantly diverse types of carcinomas (n=906), including 30 NMCs. Split-apart FISH for NUT rearrangement was used as a "gold standard" diagnostic test for NMC. C52 immunoreactivity among carcinomas was confined to NMCs. IHC staining had a sensitivity of 87%, a specificity of 100%, a negative predictive value of 99%, and a positive predictive value of 100%. Two new cases of NMC containing BRD4-NUT fusions were detected by C52 IHC, but missed by conventional FISH. In both instances, these tumors contained cryptic BRD4-NUT rearrangements, as confirmed by FISH using a refined set of probes. Some germ cell tumors, including 64% of dysgerminomas, showed weak NUT immunoreactivity, consistent with the expression of NUT in normal germ cells. We conclude that IHC staining with the C52 monoclonal antibody is a highly sensitive and specific test that reliably distinguishes NMC from other forms of carcinoma. The NUT antibody is being prepared for commercial release and will be available in the near future.

Download full-text


Available from: Seung-Mo Hong, Jan 14, 2014
63 Reads
  • Source
    • "Diagnostic immunohistochemistry of a human NMC was performed as described (Haack et al. 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: NUT midline carcinoma (NMC), a subtype of squamous cell cancer, is one of the most aggressive human solid malignancies known. NMC is driven by the creation of a translocation oncoprotein, BRD4-NUT, which blocks differentiation and drives growth of NMC cells. BRD4-NUT forms distinctive nuclear foci in patient tumors, which we found correlate with ∼100 unprecedented, hyperacetylated expanses of chromatin that reach up to 2 Mb in size. These "megadomains" appear to be the result of aberrant, feed-forward loops of acetylation and binding of acetylated histones that drive transcription of underlying DNA in NMC patient cells and naïve cells induced to express BRD4-NUT. Megadomain locations are typically cell lineage-specific; however, the cMYC and TP63 regions are targeted in all NMCs tested and play functional roles in tumor growth. Megadomains appear to originate from select pre-existing enhancers that progressively broaden but are ultimately delimited by topologically associating domain (TAD) boundaries. Therefore, our findings establish a basis for understanding the powerful role played by large-scale chromatin organization in normal and aberrant lineage-specific gene transcription. © 2015 Alekseyenko et al.; Published by Cold Spring Harbor Laboratory Press.
    Genes & Development 07/2015; 29(14):1507-1523. DOI:10.1101/gad.267583.115 · 10.80 Impact Factor
  • Source
    • "In the present article, we describe the first case of an NSD3-NUT rearrangement identified in the primary tissue of an NMC of the lung; the NMC was diagnosed using immunohistochemistry with a highly sensitive and specific anti-NUT monoclonal antibody [11]. In addition, a NSD3-NUT fusion gene was successfully identified using 5 -rapid amplification of the cDNA end (RACE) and was validated using FISH. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Nuclear protein in testis (NUT) midline carcinoma (NMC) is a rare, aggressive malignancy. Only two pediatric and three adult cases of pulmonary NMCs have been documented. In more than two-thirds of NMC cases, a gene fusion between NUT and BRD4 or BRD3 has been documented; other fusions are rare. A 36-year-old woman was admitted because of a rapidly progressing tumor of the lung with metastases to the breast and bone. A biopsy from the lung tumor revealed an undifferentiated neoplasm exhibiting round to oval nuclei with vesicular chromatin, prominent nucleoli, and scant cytoplasm. Immunohistochemical staining demonstrated focal EMA, cytokeratin AE1/AE3, cytokeratin CAM 5.2, p63, CD138, and vimentin positivity. Finally, the nuclear staining pattern for NUT confirmed a histopathological diagnosis of NMC. A 5'- rapid amplification of the cDNA end (RACE) procedure successfully identified the partner of the NUT translocation as NSD3, a recently discovered partner. Fluorescence in situ hybridization confirmed the NSD3-NUT gene rearrangement, whereas a BRD3/4-NUT fusion gene was not detected. We herein describe the first case of an NSD3-NUT-expressing NMC of the lung. The further accumulation of variant NMCs should provide clues to the establishment of new individualized therapy for NMCs. Copyright © 2014 Elsevier GmbH. All rights reserved.
    Pathology - Research and Practice 11/2014; 211(5). DOI:10.1016/j.prp.2014.10.013 · 1.40 Impact Factor
  • Source
    • "for use in immunohistochemistry has been developed for widespread application.(Haack et al., 2009). The immunohistochemical assay can detect the NUT protein in NMC, whose expression in normal mature adult tissue is restricted to the testis. With the use of the immunohistochemical assay it became clear that NMC is not restricted to younger patients but affects all age groups (French, 2012). NMC is often widely metastatic and unresect"
    [Show abstract] [Hide abstract]
    ABSTRACT: Fig. 1. A. Coronal CT image of the chest during chemotherapy treatment, indicating marked adverse change from time of diagnosis. There is encasement of the aorta and great vessels, and occlusion of the pulmonary veins and left mainstem bronchus. The mass measures approximately 10 cm by 11 cm and there are multiple loculations of fluid and tumor contributing to the pronounced mediastinal shift. B. Coronal CT image of the abdomen and pelvis at the time of diagnosis. There is a complex multilobular pelvic mass arising from the left ovary measuring 15 cm × 12 cm. Also noted is a paraaortic nodal mass measuring 5 cm.
    Gynecologic Oncology Reports 01/2012; 3:1–3. DOI:10.1016/j.gynor.2012.09.004
Show more